Regina Thurman, MD
Physical Medicine & Rehabilitation · Conway, ARNPI 1689682353
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,257 of the $1,927 with a category attached, or 65.2%. Medtronic accounts for 65.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $1,136, 2.0 times the $557 reported in 2019. Among physical medicine & rehabilitation clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $27.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Pfizer$157
- Collegium Pharmaceutical, Inc.$112
- Daiichi Sankyo Inc.$89
- Shionogi Inc$45
- Takeda Pharmaceuticals U.S.A., Inc.$42
- plus $218 from 12 others
What the payments were for
- Travel & lodging$67135%
- Food & beverage$1,25765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $1,264 |
| Pfizer | 13 | $157 |
| Collegium Pharmaceutical, Inc. | 8 | $112 |
| Daiichi Sankyo Inc. | 5 | $89 |
| Shionogi Inc | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Zyla Life Sciences, Inc. | 3 | $40 |
| Amgen | 2 | $31 |
| Vertex | 1 | $23 |
| Valinor Pharma, LLC | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $17 |
| Abbott | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Novartis | 1 | $11 |
| Neuronetics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$654
How this compares
$1,927 in reported general payments places this provider in the 95th percentile of 44 physical medicine & rehabilitation providers in Arkansas.
See all physical medicine & rehabilitation providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 33 | $24,698 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 574 | $19,238 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 477 | $16,777 |
| Xtampza ErOxycodone Myristate | 41 | $16,529 |
| Oxycodone Hcl | 769 | $14,541 |
| MovantikNaloxegol Oxalate | 22 | $11,066 |
| Buprenorphine | 32 | $6,561 |
| Morphine Sulfate ErMorphine Sulfate | 249 | $4,925 |
| Morphine Sulfate | 119 | $3,673 |
| Gabapentin | 191 | $2,579 |
| Naloxone Hcl | 23 | $1,684 |
| Hydromorphone Hcl | 83 | $1,378 |
| Pregabalin | 81 | $1,320 |
| Tizanidine Hcl | 80 | $1,166 |
| Cyclobenzaprine Hcl | 89 | $954 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $112 | $41,22774 claims |
| Redhill Biopharma Inc.Movantik | $17 | $11,06622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 44 physical medicine & rehabilitation providers in Arkansas.
Other physical medicine & rehabilitation in Conway
- Cale WhiteLittle Rock$7K
- Rodrigo CaymeLittle Rock$3K
- Ibrahim Samarra'eLittle Rock$2K
- Lauren DymnaLittle Rock$1K
- Ross HardyHot Springs$750
- Kevin CollinsNorth Little Rock$545
- Drake HardyLittle Rock$334
- Mark WrenTexarkana$285
- Kevin MeansLittle Rock$246
- Ana MichunovichJonesboro$243
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.